The DSTN Knockout HEK293T Polyclonal Cells are a pool of CRISPR/Cas9-edited human embryonic kidney cells engineered to disrupt the DSTN gene, generating a loss-of-function model for investigating actin dynamics. This polyclonal knockout population, derived via transient CRISPR/Cas9 delivery, enables the study of destrin deficiency in a heterogeneous HEK293T background, avoiding clonal artifacts while retaining the advantages of a well-characterized host line. The disruption targets the gene encoding destrin, an actin-depolymerizing factor critical for cytoskeletal reorganization.
The host cell line, HEK293T, originated from HEK293 cells transformed with sheared adenovirus type 5 DNA, and stably expresses the SV40 large T antigen. This antigenic expression promotes episomal replication of vectors containing the SV40 origin, significantly enhancing transgene expression and viral production. HEK293T cells are widely employed in biomedical research due to their high transfection efficiency, robust protein production capacity, and ease of culture, making them an ideal chassis for gene-editing applications and subsequent functional analyses of cytoskeletal factors.
Destrin, encoded by DSTN, functions as a core actin-depolymerizing factor that severs filamentous actin (F-actin) and enhances actin subunit turnover. Its activity is tightly controlled by reversible phosphorylation: LIM kinase (LIMK1/2) phosphorylates destrin at serine 3, inhibiting its severing function, while slingshot phosphatase (SSH1) reactivates it by dephosphorylation. These events occur downstream of Rho family GTPases??RhoA, RAC1, and CDC42??and their effectors, including ROCK and PAK1. Destrin directly interacts with both F-actin and monomeric G-actin, as well as with cofilin and 14-3-3 proteins, positioning it at the nexus of signal-regulated actin remodeling. Consequently, DSTN knockout disrupts the balance between actin polymerization and depolymerization, impacting processes such as lamellipodia protrusion, cell motility, and cytokinesis.
In the HEK293T context, loss of destrin function permits dissection of actin-dependent pathways without the complicating factors of specialized cytoskeletal architectures found in highly differentiated cells. The presence of SV40 large T antigen may influence cell cycle progression and chromatin organization, providing a unique backdrop to study how actin dynamics intersect with proliferation and nuclear events. The polyclonal nature of this knockout product offers a spectrum of gene-disruption efficiencies, allowing researchers to assess dosage-dependent effects and avoid clonal adaptation artifacts commonly encountered in monoclonal lines.
These cells are suitable for a broad array of assays, including immunofluorescence and phalloidin staining to visualize actin filament organization, Western blotting with phospho-Ser3-specific antibodies to monitor destrin phosphorylation status, and co-immunoprecipitation to examine interactions with actin or regulatory partners. Functional studies such as scratch wound migration assays and time-lapse imaging of lamellipodial dynamics can delineate the role of destrin in cell motility and invasion, relevant to cancer metastasis models. Additionally, flow cytometry can be employed to assess cell cycle perturbations, and RT-qPCR to profile downstream transcriptional responses. For further details or to purchase, please contact Ascent Research.
